SeaCrest Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

SeaCrest Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,331	Closed	-$100K	–	1259
2022 Q2	$100K	Buy	+1,331	New	+$101K	0.01%	859
2022 Q1	–	Sell	-2,754	Closed	-$223K	–	755
2021 Q4	$223K	Hold	2,754	–	–	0.02%	610
2021 Q3	$213K	Sell	2,754 -377	-12%	-$30.4K	0.03%	609
2021 Q2	$252K	Buy	3,131 +1	+0%	+$79	0.03%	559
2021 Q1	$247K	Hold	3,130	–	–	0.03%	525
2020 Q4	$223K	Sell	3,130 -150	-5%	-$10K	0.03%	533
2020 Q3	$209K	Sell	3,280 -337	-9%	-$22K	0.03%	505
2020 Q2	$234K	Sell	3,617 -1,992	-36%	-$124K	0.04%	462
2020 Q1	$309K	Sell	5,609 -11	-0.2%	-$670	0.07%	320
2019 Q4	$364K	Buy	5,620 +1	+0%	+$61	0.06%	349
2019 Q3	$318K	Sell	5,619 -1,079	-16%	-$62.1K	0.06%	376
2019 Q2	$403K	Hold	6,698	–	–	0.08%	295
2019 Q1	$436K	Buy	6,698 +1	+0%	+$66	0.07%	266
2018 Q4	$418K	Sell	6,697 -949	-12%	-$64.1K	0.09%	238
2018 Q3	$562K	Sell	7,646 -428	-5%	-$30.7K	0.1%	229
2018 Q2	$543K	Sell	8,074 -17	-0.2%	-$1.09K	0.1%	231
2018 Q1	$505K	Hold	8,091	–	–	0.09%	238
2017 Q4	$519K	Buy	+8,091	New	+$519K	0.09%	226

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SeaCrest Wealth Management's PJP Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2022, closing a stake of 1,331 shares — an estimated $100K sold.

SeaCrest Wealth Management first reported a position in PJP in Q4 2017 and held it in 18 quarters. The position peaked at $562K in Q3 2018. 81 funds tracked by Wall St. Rank hold PJP as of Q3 2022.

SeaCrest Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
SeaCrest Wealth Management sold 1,331 Invesco Pharmaceuticals ETF shares in Q3 2022, an estimated $100K.
SeaCrest Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and held it in 18 quarters.
SeaCrest Wealth Management's Invesco Pharmaceuticals ETF position peaked at $562K in Q3 2018.
81 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.